Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part II: Supporting details

James Swanson, L. Eugene Arnold, Helena Kraemer, Lily Hechtman, Brooke Molina, Stephen Hinshaw, Benedetto Vitiello, Peter Jensen, Ken Steinhoff, Marc Lerner, Laurence Greenhill, Howard Abikoff, Karen Wells, Jeffery Epstein, Glen Elliott, Jeffrey Newcorn, Betsy Hoza, Timothy Wigal

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment "as usual" in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD.

Original languageEnglish (US)
Pages (from-to)15-43
Number of pages29
JournalJournal of Attention Disorders
Volume12
Issue number1
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Combined Modality Therapy
Randomized Controlled Trials
Confusion
Behavior Therapy
Therapeutics
Uncertainty
Research Personnel

Keywords

  • Attention-deficit/hyperactivity disorder
  • Behavior modification
  • Multimodal treatment
  • Randomized clinical trial
  • Stimulant medication

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA) : Part II: Supporting details. / Swanson, James; Arnold, L. Eugene; Kraemer, Helena; Hechtman, Lily; Molina, Brooke; Hinshaw, Stephen; Vitiello, Benedetto; Jensen, Peter; Steinhoff, Ken; Lerner, Marc; Greenhill, Laurence; Abikoff, Howard; Wells, Karen; Epstein, Jeffery; Elliott, Glen; Newcorn, Jeffrey; Hoza, Betsy; Wigal, Timothy.

In: Journal of Attention Disorders, Vol. 12, No. 1, 07.2008, p. 15-43.

Research output: Contribution to journalArticle

Swanson, J, Arnold, LE, Kraemer, H, Hechtman, L, Molina, B, Hinshaw, S, Vitiello, B, Jensen, P, Steinhoff, K, Lerner, M, Greenhill, L, Abikoff, H, Wells, K, Epstein, J, Elliott, G, Newcorn, J, Hoza, B & Wigal, T 2008, 'Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part II: Supporting details', Journal of Attention Disorders, vol. 12, no. 1, pp. 15-43. https://doi.org/10.1177/1087054708319525
Swanson, James ; Arnold, L. Eugene ; Kraemer, Helena ; Hechtman, Lily ; Molina, Brooke ; Hinshaw, Stephen ; Vitiello, Benedetto ; Jensen, Peter ; Steinhoff, Ken ; Lerner, Marc ; Greenhill, Laurence ; Abikoff, Howard ; Wells, Karen ; Epstein, Jeffery ; Elliott, Glen ; Newcorn, Jeffrey ; Hoza, Betsy ; Wigal, Timothy. / Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA) : Part II: Supporting details. In: Journal of Attention Disorders. 2008 ; Vol. 12, No. 1. pp. 15-43.
@article{64cec0e09b6541e5b81a2b38d90ad0ee,
title = "Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA): Part II: Supporting details",
abstract = "Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment {"}as usual{"} in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD.",
keywords = "Attention-deficit/hyperactivity disorder, Behavior modification, Multimodal treatment, Randomized clinical trial, Stimulant medication",
author = "James Swanson and Arnold, {L. Eugene} and Helena Kraemer and Lily Hechtman and Brooke Molina and Stephen Hinshaw and Benedetto Vitiello and Peter Jensen and Ken Steinhoff and Marc Lerner and Laurence Greenhill and Howard Abikoff and Karen Wells and Jeffery Epstein and Glen Elliott and Jeffrey Newcorn and Betsy Hoza and Timothy Wigal",
year = "2008",
month = "7",
doi = "10.1177/1087054708319525",
language = "English (US)",
volume = "12",
pages = "15--43",
journal = "Journal of Attention Disorders",
issn = "1087-0547",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the multimodal treatment study of children with ADHD (MTA)

T2 - Part II: Supporting details

AU - Swanson, James

AU - Arnold, L. Eugene

AU - Kraemer, Helena

AU - Hechtman, Lily

AU - Molina, Brooke

AU - Hinshaw, Stephen

AU - Vitiello, Benedetto

AU - Jensen, Peter

AU - Steinhoff, Ken

AU - Lerner, Marc

AU - Greenhill, Laurence

AU - Abikoff, Howard

AU - Wells, Karen

AU - Epstein, Jeffery

AU - Elliott, Glen

AU - Newcorn, Jeffrey

AU - Hoza, Betsy

AU - Wigal, Timothy

PY - 2008/7

Y1 - 2008/7

N2 - Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment "as usual" in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD.

AB - Objective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment "as usual" in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD.

KW - Attention-deficit/hyperactivity disorder

KW - Behavior modification

KW - Multimodal treatment

KW - Randomized clinical trial

KW - Stimulant medication

UR - http://www.scopus.com/inward/record.url?scp=45549087705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549087705&partnerID=8YFLogxK

U2 - 10.1177/1087054708319525

DO - 10.1177/1087054708319525

M3 - Article

C2 - 18573924

AN - SCOPUS:45549087705

VL - 12

SP - 15

EP - 43

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

SN - 1087-0547

IS - 1

ER -